Cargando…
Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
BACKGROUND: The aim of the current PodoNet registry analysis was to evaluate the outcome of steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with intensified immunosuppression (IIS), focusing on the potential for spontaneous remission and the role of angiotensin blockade...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060323/ https://www.ncbi.nlm.nih.gov/pubmed/36315273 http://dx.doi.org/10.1007/s00467-022-05762-4 |
_version_ | 1785017074387517440 |
---|---|
author | Trautmann, Agnes Seide, Svenja Lipska-Ziętkiewicz, Beata S. Ozaltin, Fatih Szczepanska, Maria Azocar, Marta Jankauskiene, Augustina Zurowska, Alexandra Caliskan, Salim Saeed, Bassam Morello, William Emma, Francesco Litwin, Mieczyslaw Tsygin, Alexey Fomina, Svitlana Wasilewska, Anna Melk, Anette Benetti, Elisa Gellermann, Jutta Stajic, Natasa Tkaczyk, Marcin Baiko, Sergey Prikhodina, Larisa Csaicsich, Dagmar Medynska, Anna Krisam, Regina Breitschwerdt, Heike Schaefer, Franz |
author_facet | Trautmann, Agnes Seide, Svenja Lipska-Ziętkiewicz, Beata S. Ozaltin, Fatih Szczepanska, Maria Azocar, Marta Jankauskiene, Augustina Zurowska, Alexandra Caliskan, Salim Saeed, Bassam Morello, William Emma, Francesco Litwin, Mieczyslaw Tsygin, Alexey Fomina, Svitlana Wasilewska, Anna Melk, Anette Benetti, Elisa Gellermann, Jutta Stajic, Natasa Tkaczyk, Marcin Baiko, Sergey Prikhodina, Larisa Csaicsich, Dagmar Medynska, Anna Krisam, Regina Breitschwerdt, Heike Schaefer, Franz |
author_sort | Trautmann, Agnes |
collection | PubMed |
description | BACKGROUND: The aim of the current PodoNet registry analysis was to evaluate the outcome of steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with intensified immunosuppression (IIS), focusing on the potential for spontaneous remission and the role of angiotensin blockade on proteinuria reduction. METHODS: Ninety-five pediatric patients who did not receive any IIS were identified in the PodoNet Registry. Competing risk analyses were performed on 67 patients with nephrotic-range proteinuria at disease onset to explore the cumulative rates of complete or partial remission or progression to kidney failure, stratified by underlying etiology (genetic vs. non-genetic SRNS). In addition, Cox proportional hazard analysis was performed to identify factors predicting proteinuria remission. RESULTS: Eighteen of 31 (58.1%) patients with non-genetic SRNS achieved complete remission without IIS, with a cumulative likelihood of 46.2% at 1 year and 57.7% at 2 years. Remission was sustained in 11 children, and only two progressed to kidney failure. In the genetic subgroup (n = 27), complete resolution of proteinuria occurred very rarely and was never sustained; 6 (21.7%) children progressed to kidney failure at 3 years. Almost all children (96.8%) received proteinuria-lowering renin–angiotensin–aldosterone system (RAAS) antagonist treatment. On antiproteinuric treatment, partial remission was achieved in 7 of 31 (22.6%) children with non-genetic SRNS and 9 of 27 children (33.3%) with genetic SRNS. CONCLUSION: Our results demonstrate that spontaneous complete remission can occur in a substantial fraction of children with non-genetic SRNS and milder clinical phenotype. RAAS blockade increases the likelihood of partial remission of proteinuria in all forms of SRNS. GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05762-4. |
format | Online Article Text |
id | pubmed-10060323 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-100603232023-03-31 Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression Trautmann, Agnes Seide, Svenja Lipska-Ziętkiewicz, Beata S. Ozaltin, Fatih Szczepanska, Maria Azocar, Marta Jankauskiene, Augustina Zurowska, Alexandra Caliskan, Salim Saeed, Bassam Morello, William Emma, Francesco Litwin, Mieczyslaw Tsygin, Alexey Fomina, Svitlana Wasilewska, Anna Melk, Anette Benetti, Elisa Gellermann, Jutta Stajic, Natasa Tkaczyk, Marcin Baiko, Sergey Prikhodina, Larisa Csaicsich, Dagmar Medynska, Anna Krisam, Regina Breitschwerdt, Heike Schaefer, Franz Pediatr Nephrol Original Article BACKGROUND: The aim of the current PodoNet registry analysis was to evaluate the outcome of steroid-resistant nephrotic syndrome (SRNS) in children who were not treated with intensified immunosuppression (IIS), focusing on the potential for spontaneous remission and the role of angiotensin blockade on proteinuria reduction. METHODS: Ninety-five pediatric patients who did not receive any IIS were identified in the PodoNet Registry. Competing risk analyses were performed on 67 patients with nephrotic-range proteinuria at disease onset to explore the cumulative rates of complete or partial remission or progression to kidney failure, stratified by underlying etiology (genetic vs. non-genetic SRNS). In addition, Cox proportional hazard analysis was performed to identify factors predicting proteinuria remission. RESULTS: Eighteen of 31 (58.1%) patients with non-genetic SRNS achieved complete remission without IIS, with a cumulative likelihood of 46.2% at 1 year and 57.7% at 2 years. Remission was sustained in 11 children, and only two progressed to kidney failure. In the genetic subgroup (n = 27), complete resolution of proteinuria occurred very rarely and was never sustained; 6 (21.7%) children progressed to kidney failure at 3 years. Almost all children (96.8%) received proteinuria-lowering renin–angiotensin–aldosterone system (RAAS) antagonist treatment. On antiproteinuric treatment, partial remission was achieved in 7 of 31 (22.6%) children with non-genetic SRNS and 9 of 27 children (33.3%) with genetic SRNS. CONCLUSION: Our results demonstrate that spontaneous complete remission can occur in a substantial fraction of children with non-genetic SRNS and milder clinical phenotype. RAAS blockade increases the likelihood of partial remission of proteinuria in all forms of SRNS. GRAPHICAL ABSTRACT: [Figure: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05762-4. Springer Berlin Heidelberg 2022-10-31 2023 /pmc/articles/PMC10060323/ /pubmed/36315273 http://dx.doi.org/10.1007/s00467-022-05762-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Trautmann, Agnes Seide, Svenja Lipska-Ziętkiewicz, Beata S. Ozaltin, Fatih Szczepanska, Maria Azocar, Marta Jankauskiene, Augustina Zurowska, Alexandra Caliskan, Salim Saeed, Bassam Morello, William Emma, Francesco Litwin, Mieczyslaw Tsygin, Alexey Fomina, Svitlana Wasilewska, Anna Melk, Anette Benetti, Elisa Gellermann, Jutta Stajic, Natasa Tkaczyk, Marcin Baiko, Sergey Prikhodina, Larisa Csaicsich, Dagmar Medynska, Anna Krisam, Regina Breitschwerdt, Heike Schaefer, Franz Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression |
title | Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression |
title_full | Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression |
title_fullStr | Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression |
title_full_unstemmed | Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression |
title_short | Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression |
title_sort | outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060323/ https://www.ncbi.nlm.nih.gov/pubmed/36315273 http://dx.doi.org/10.1007/s00467-022-05762-4 |
work_keys_str_mv | AT trautmannagnes outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT seidesvenja outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT lipskazietkiewiczbeatas outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT ozaltinfatih outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT szczepanskamaria outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT azocarmarta outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT jankauskieneaugustina outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT zurowskaalexandra outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT caliskansalim outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT saeedbassam outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT morellowilliam outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT emmafrancesco outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT litwinmieczyslaw outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT tsyginalexey outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT fominasvitlana outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT wasilewskaanna outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT melkanette outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT benettielisa outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT gellermannjutta outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT stajicnatasa outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT tkaczykmarcin outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT baikosergey outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT prikhodinalarisa outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT csaicsichdagmar outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT medynskaanna outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT krisamregina outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT breitschwerdtheike outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT schaeferfranz outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression AT outcomesofsteroidresistantnephroticsyndromeinchildrennottreatedwithintensifiedimmunosuppression |